14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

RTRX Predictions History

2 years ago
JS predicted that RTRX for 2021-09-10 is going $24.02 (2.00%)

2 years ago
JS predicted that RTRX for 2021-05-18 is going $19.02 (3.65%)

2 years ago
bahill14 predicted that RTRX for 2021-05-18 is going

Rank:

4 years ago
NameNotImportant predicted that RTRX for 2019-05-06 is going $20.02 (2.77%)

5 years ago
NameNotImportant predicted that RTRX for 2019-05-02 is going $24.29 (27.11%)

5 years ago
NameNotImportant predicted that RTRX for 2019-04-29 is going $19.86 (4.31%)

5 years ago
NameNotImportant predicted that RTRX for 2019-04-22 is going $20.26 (1.05%)

7 years ago
PumpTheseNumbers predicted that RTRX for 2016-05-24 is going $16.63 (-1.01%)

7 years ago
PumpTheseNumbers predicted that RTRX for 2016-05-20 is going $15.66 (-3.51%)

7 years ago
JS predicted that RTRX for 2016-05-19 is going $16.04 (-1.78%)

Click to get the best stock tips daily for free!

About Retrophin

Retrophin Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious, catastrophic, or rare diseases. Its product line includes Cholbam, a cholic acid for the treatment of bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of peroxisomal disorders, such as Zellweger spectrum disorders in patients who exhibit manifestations of li... RTRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT